Insulet Total Assets Growth & History (PODD)
Insulet's total assets was $3.19B for fiscal 2025.
View full Insulet company overviewInsulet annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.19B | $102.7M | +3.33% |
| 2024 | 2024-12-31 | $3.09B | $499.5M | +19.30% |
| 2023 | 2023-12-31 | $2.59B | $337.1M | +14.97% |
| 2022 | 2022-12-31 | $2.25B | $202.3M | +9.87% |
| 2021 | 2021-12-31 | $2.05B | $175.9M | +9.39% |
| 2020 | 2020-12-31 | $1.87B | $730.0M | +63.87% |
| 2019 | 2019-12-31 | $1.14B | $214.2M | +23.06% |
| 2018 | 2018-12-31 | $928.7M | $112.0M | +13.71% |
| 2017 | 2017-12-31 | $816.7M | $360.1M | +78.86% |
| 2016 | 2016-12-31 | $456.6M | $181.5M | +65.98% |
| 2015 | 2015-12-31 | $275.1M | −$22.1M | −7.42% |
| 2014 | 2014-12-31 | $297.2M | $9.2M | +3.20% |
| 2013 | 2013-12-31 | $288.0M | $89.9M | +45.39% |
| 2012 | 2012-12-31 | $198.1M | −$23.3M | −10.51% |
| 2011 | 2011-12-31 | $221.3M | $65.1M | +41.66% |
| 2010 | 2010-12-31 | $156.2M | — | — |
Insulet quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.17B | −$304.1M | −8.77% |
| Q1 2026 | 2026-03-31 | $2.99B | −$530.1M | −15.07% |
| Q4 2025 | 2025-12-31 | $3.19B | $102.7M | +3.33% |
| Q3 2025 | 2025-09-30 | $3.03B | $3.9M | +0.13% |
| Q2 2025 | 2025-06-30 | $3.47B | $587.6M | +20.39% |
| Q1 2025 | 2025-03-31 | $3.52B | $893.3M | +34.04% |
| Q4 2024 | 2024-12-31 | $3.09B | $499.5M | +19.30% |
| Q3 2024 | 2024-09-30 | $3.03B | $557.7M | +22.60% |
| Q2 2024 | 2024-06-30 | $2.88B | $495.8M | +20.78% |
| Q1 2024 | 2024-03-31 | $2.62B | $334.9M | +14.63% |
| Q4 2023 | 2023-12-31 | $2.59B | $337.1M | +14.97% |
| Q3 2023 | 2023-09-30 | $2.47B | $301.5M | +13.92% |
| Q2 2023 | 2023-06-30 | $2.39B | $272.1M | +12.87% |
| Q1 2023 | 2023-03-31 | $2.29B | $219.9M | +10.63% |
| Q4 2022 | 2022-12-31 | $2.25B | $202.3M | +9.87% |
| Q3 2022 | 2022-09-30 | $2.17B | $167.3M | +8.37% |
| Q2 2022 | 2022-06-30 | $2.11B | $190.0M | +9.88% |
| Q1 2022 | 2022-03-31 | $2.07B | $229.1M | +12.45% |
| Q4 2021 | 2021-12-31 | $2.05B | $175.9M | +9.39% |
| Q3 2021 | 2021-09-30 | $2.00B | $288.3M | +16.85% |
| Q2 2021 | 2021-06-30 | $1.92B | $297.0M | +18.26% |
| Q1 2021 | 2021-03-31 | $1.84B | $731.9M | +66.04% |
| Q4 2020 | 2020-12-31 | $1.87B | $730.0M | +63.87% |
| Q3 2020 | 2020-09-30 | $1.71B | $442.2M | +34.86% |
| Q2 2020 | 2020-06-30 | $1.63B | $649.0M | +66.38% |
| Q1 2020 | 2020-03-31 | $1.11B | $155.6M | +16.33% |
| Q4 2019 | 2019-12-31 | $1.14B | $214.2M | +23.06% |
| Q3 2019 | 2019-09-30 | $1.27B | $382.1M | +43.11% |
| Q2 2019 | 2019-06-30 | $977.7M | $138.9M | +16.55% |
| Q1 2019 | 2019-03-31 | $952.6M | $122.8M | +14.81% |
| Q4 2018 | 2018-12-31 | $928.7M | $112.0M | +13.71% |
| Q3 2018 | 2018-09-30 | $886.3M | $386.0M | +77.14% |
| Q2 2018 | 2018-06-30 | $838.9M | $379.5M | +82.63% |
| Q1 2018 | 2018-03-31 | $829.8M | $384.8M | +86.48% |
| Q4 2017 | 2017-12-31 | $816.7M | $360.1M | +78.86% |
| Q3 2017 | 2017-09-30 | $500.3M | $47.2M | +10.40% |
| Q2 2017 | 2017-06-30 | $459.3M | $196.3M | +74.62% |
| Q1 2017 | 2017-03-31 | $445.0M | $190.2M | +74.65% |
| Q4 2016 | 2016-12-31 | $456.6M | $181.5M | +65.98% |
| Q3 2016 | 2016-09-30 | $453.2M | $160.1M | +54.61% |
| Q2 2016 | 2016-06-30 | $263.0M | −$37.3M | −12.43% |
| Q1 2016 | 2016-03-31 | $254.8M | −$50.9M | −16.66% |
| Q4 2015 | 2015-12-31 | $275.1M | −$22.1M | −7.42% |
| Q3 2015 | 2015-09-30 | $293.1M | −$8.1M | −2.68% |
| Q2 2015 | 2015-06-30 | $300.4M | −$24.9M | −7.66% |
| Q1 2015 | 2015-03-31 | $305.7M | $17.2M | +5.96% |
| Q4 2014 | 2014-12-31 | $297.2M | $9.2M | +3.20% |
| Q3 2014 | 2014-09-30 | $301.2M | $11.7M | +4.04% |
| Q2 2014 | 2014-06-30 | $325.3M | $39.2M | +13.69% |
| Q1 2014 | 2014-03-31 | $288.5M | $7.6M | +2.72% |
| Q4 2013 | 2013-12-31 | $288.0M | $89.9M | +45.39% |
| Q3 2013 | 2013-09-30 | $289.5M | $86.1M | +42.34% |
| Q2 2013 | 2013-06-30 | $286.2M | $82.5M | +40.49% |
| Q1 2013 | 2013-03-31 | $280.9M | $65.2M | +30.24% |
| Q4 2012 | 2012-12-31 | $198.1M | −$23.3M | −10.51% |
| Q3 2012 | 2012-09-30 | $203.4M | −$25.0M | −10.93% |
| Q2 2012 | 2012-06-30 | $203.7M | −$22.5M | −9.95% |
| Q1 2012 | 2012-03-31 | $215.7M | — | — |
| Q4 2011 | 2011-12-31 | $221.3M | $65.1M | +41.66% |
| Q3 2011 | 2011-09-30 | $228.3M | — | — |
| Q2 2011 | 2011-06-30 | $226.2M | — | — |
| Q4 2010 | 2010-12-31 | $156.2M | — | — |
Insulet total assets trends
Over the last five fiscal years, Insulet's total assets increased from $1.87B to $3.19B, a change of $1.32B. The latest reported quarter, Q2 2026, shows $3.17B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Insulet source filings ↗